1Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands. 2Laboratory of Experimental Intensive Care and Anesthesiology, Academic Medical Center, Amsterdam, The Netherlands. 3Department of Medical Informatics, Academic Medical Center, Amsterdam, The Netherlands. 4Department of Intensive Care, Academic Medical Center, Amsterdam, The Netherlands. 5Department of Intensive Care, Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands.
Crit Care Med. 2017 Feb;45(2):187-195. doi: 10.1097/CCM.0000000000002084.
Emerging evidence has shown the potential risks of arterial hyperoxia, but the lack of a clinical definition and methodologic limitations hamper the interpretation and clinical relevance of previous studies. Our purpose was to evaluate previously used and newly constructed metrics of arterial hyperoxia and systematically assess their association with clinical outcomes in different subgroups in the ICU.
Observational cohort study.
Three large tertiary care ICUs in the Netherlands.
A total of 14,441 eligible ICU patients.
None.
In total, 295,079 arterial blood gas analyses, including the PaO2, between July 2011 and July 2014 were extracted from the patient data management system database. Data from all admissions with more than one PaO2 measurement were supplemented with anonymous demographic and admission and discharge data from the Dutch National Intensive Care Evaluation registry. Mild hyperoxia was defined as PaO2 between 120 and 200 mm Hg; severe hyperoxia as PaO2 greater than 200 mm Hg. Characteristics of existing and newly constructed metrics for arterial hyperoxia were examined, and the associations with hospital mortality (primary outcome), ICU mortality, and ventilator-free days and alive at day 28 were retrospectively analyzed using regression models in different subgroups of patients. Severe hyperoxia was associated with higher mortality rates and fewer ventilator-free days in comparison to both mild hyperoxia and normoxia for all metrics except for the worst PaO2. Adjusted effect estimates for conditional mortality were larger for severe hyperoxia than for mild hyperoxia. This association was found both within and beyond the first 24 hours of admission and was consistent for large subgroups. The largest point estimates were found for the exposure identified by the average PaO2, closely followed by the median PaO2, and these estimates differed substantially between subsets. Time spent in hyperoxia showed a linear and positive relationship with hospital mortality.
Our results suggest that we should limit the PaO2 levels of critically ill patients within a safe range, as we do with other physiologic variables. Analytical metrics of arterial hyperoxia should be judiciously considered when interpreting and comparing study results and future studies are needed to validate our findings in a randomized fashion design.
新出现的证据表明动脉血过度氧合存在潜在风险,但由于缺乏临床定义和方法学限制,先前研究的解释和临床相关性受到阻碍。我们的目的是评估先前使用和新构建的动脉血过度氧合指标,并系统评估它们与 ICU 不同亚组临床结局的相关性。
观察性队列研究。
荷兰的 3 家大型三级护理 ICU。
共纳入 14441 名符合条件的 ICU 患者。
无。
从患者数据管理系统数据库中提取了 2011 年 7 月至 2014 年 7 月期间的 295079 份动脉血气分析,包括 PaO2。所有至少有 1 次 PaO2 测量值的入院患者的数据均由荷兰国家重症监护评估登记处的匿名人口统计学和入院及出院数据补充。轻度氧合定义为 PaO2 为 120 至 200mmHg;重度氧合定义为 PaO2 大于 200mmHg。检查了现有的和新构建的动脉血过度氧合指标的特征,并使用回归模型在不同患者亚组中回顾性分析了这些指标与住院死亡率(主要结局)、ICU 死亡率以及无机械通气天数和 28 天存活的相关性。与轻度氧合和正常氧合相比,除了最差的 PaO2 外,所有指标的重度氧合均与更高的死亡率和更少的无机械通气天数相关。与轻度氧合相比,严重氧合的调整后死亡风险估计值更大。这种相关性在入院后 24 小时内和之后均存在,并且在大的亚组中一致。最大的点估计值出现在平均 PaO2 确定的暴露中,其次是中位数 PaO2,这些估计值在亚组之间差异很大。过度氧合时间与住院死亡率呈线性正相关。
我们的结果表明,我们应该将危重症患者的 PaO2 水平限制在安全范围内,就像我们对待其他生理变量一样。在解释和比较研究结果时,应谨慎考虑动脉血过度氧合的分析指标,需要进一步的研究来验证我们的发现,并以随机设计的方式进行验证。